FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

126085005: Halobetasol propionate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
6284015 Halobetasol propionate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730002015 Halobetasol propionate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Halobetasol propionate Is a Synthetic glucocorticoid false Inferred relationship Some
Halobetasol propionate Is a Synthetic glucocorticoid, fluorinated false Inferred relationship Some
Halobetasol propionate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Halobetasol true Inferred relationship Some
Halobetasol propionate Is a Fluorinated corticosteroid true Inferred relationship Some
Halobetasol propionate Is a Glucocorticoid (substance) true Inferred relationship Some
Halobetasol propionate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Halobetasol propionate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Halobetasol propionate Inferred relationship Some
Halobetasol propionate 0.05% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Halobetasol propionate Inferred relationship Some
Halobetasol propionate 0.05% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Halobetasol propionate Inferred relationship Some
Halobetasol propionate 500 microgram/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Halobetasol propionate Inferred relationship Some
Halobetasol propionate 500 microgram/mL cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Halobetasol propionate Inferred relationship Some 1
Halobetasol propionate 500 microgram/mL cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Halobetasol propionate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start